Burning Rock to Hold 2025 AGM on December 23 to Ratify Auditor Appointment
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 01 2025
0mins
Source: Globenewswire
- AGM Announcement: Burning Rock Biotech will hold its annual general meeting on December 23, 2025, at 10:30 a.m. in Shanghai to discuss the appointment of auditors and re-election of directors, ensuring transparency and compliance in corporate governance.
- Auditor Appointment: The meeting will consider ratifying Ernst & Young Hua Ming LLP as the auditor for the fiscal year ending December 31, 2025, with the board fully supporting this proposal to enhance the credibility of financial reporting and investor confidence.
- Director Re-election: The AGM will also address the re-election of directors Feng Deng and Licen Lisa Xu, aiming to maintain stability and continuity in leadership, which is crucial for advancing the company's strategic initiatives in precision oncology.
- Shareholder Voting Rights: Shareholders holding Class A and Class B ordinary shares as of the record date of December 1, 2025, will be entitled to attend and vote at the meeting, ensuring their engagement and influence in significant corporate decisions.
Analyst Views on BNR
About BNR
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
